Pulmatrix

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Pulmatrix and other ETFs, options, and stocks.

About PULM

Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the development and discovery of novel inhaled therapeutics products. The company was founded by David Alan Edwards, Mark J. 

CEO
Peter B. Ludlum
CEOPeter B. Ludlum
Employees
2
Employees2
Headquarters
Framingham, Massachusetts
HeadquartersFramingham, Massachusetts
Founded
2003
Founded2003
Employees
2
Employees2

PULM Key Statistics

Market cap
17.82M
Market cap17.82M
Price-Earnings ratio
-2.87
Price-Earnings ratio-2.87
Dividend yield
Dividend yield
Average volume
4.53K
Average volume4.53K
High today
$5.04
High today$5.04
Low today
$4.88
Low today$4.88
Open price
$4.88
Open price$4.88
Volume
992.00
Volume992.00
52 Week high
$10.40
52 Week high$10.40
52 Week low
$2.34
52 Week low$2.34

Stock Snapshot

As of today, Pulmatrix(PULM) shares are valued at $5.04. The company's market cap stands at 17.82M, with a P/E ratio of -2.87.

On 2025-11-13, Pulmatrix(PULM) stock traded between a low of $4.88 and a high of $5.04. Shares are currently priced at $5.04, which is +3.3% above the low and 0.0% below the high.

Pulmatrix(PULM) shares are trading with a volume of 992, against a daily average of 4.53K.

During the past year, Pulmatrix(PULM) stock moved between $2.34 at its lowest and $10.40 at its peak.

During the past year, Pulmatrix(PULM) stock moved between $2.34 at its lowest and $10.40 at its peak.

People also own

Based on the portfolios of people who own PULM. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.